Drug
Benphothiamine clinical trials
Also written Benfotiamine.
- studies test it
- 12
- open now
- 1
- in phase 3
- 2
- first study started
- 2004
Keep track of what changes. Save the benphothiamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2008 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 2
- Phase 4
- 5
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 12
Ruhr University of Bochum (3) · Weill Medical College of Cornell University (1) · Burke Medical Research Institute (1) · Albert Einstein College of Medicine (1) · Universidad de Guanajuato (1) · University of Kansas (1) · University Hospital, Aker (1) · University Medical Center Groningen (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses benphothiamine is read from its arms, and is right about nine times in ten.
Testing it · 12
- Benfotiamine Versus Vitamin B1-6-12 for Diabetic Peripheral NeuropathyRecruitingPhase 4Thammasat UniversityNCT07708233Written as Benfotiamine
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)Active, not recruitingPhase 2Weill Medical College of Cornell UniversityNCT06223360Written as Low Dose Benfotiamine
- Benfotiamine in Alzheimer's Disease: A Pilot StudyCompletedPhase 2Burke Medical Research InstituteNCT02292238Written as Benfotiamine
- Reactive Oxygen Species in the Pathogenesis of Diabetic ComplicationsCompletedNot applicableAlbert Einstein College of MedicineNCT00703989Written as benfotiamine, α-lipoic acid
- Benfotiamine Effect on Advanced Glycation End Products(AGEs) and Soluble Receptor for AGEs(sRAGE) in Diabetes Mellitus.CompletedNot applicableUniversidad de GuanajuatoNCT02772926Written as Benfotiamine
- High Dose Vitamin B1 to Reduce Abusive Alcohol UseCompletedPhase 4University of KansasNCT00680121Written as Benfotiamine
- Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)Status unknownPhase 3Diabetes SchwerpunktpraxisNCT01868191Written as Benfotiamine
- Effects of Vitamin B1 in Type 1 Diabetic PatientsCompletedPhase 1/2University Hospital, AkerNCT00117026Written as Benfotiamine
- Benfotiamine in Diabetic NephropathyCompletedPhase 4University Medical Center GroningenNCT00565318Written as Benfotiamine
- Benfotiamine Prevents Vascular Dysfunction in Healthy SmokersCompletedPhase 3Ruhr University of BochumNCT00785460Written as Benfotiamine
- Chronic Treatment With Benfotiamine Restores Endothelial Function in People With Type 2 Diabetes MellitusStatus unknownPhase 4Ruhr University of BochumNCT00446810Written as Benfotiamine
- Effects of Benfotiamine and AGE on Endothelial Function in People With DiabetesCompletedPhase 4Ruhr University of BochumNCT00437008Written as Benfotiamine 1050mg, 3 days
Codes
What other systems call benphothiamine · ClinicalTrials.gg INT002591
- MeSH (NLM) C013835benphothiamineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) Y92OUS2H9BBENFOTIAMINEConfirmed FDA, NLM
- RxNorm 18891One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C013835 | benphothiamine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | Y92OUS2H9B | BENFOTIAMINE | Confirmed FDA, NLM |
| RxNorm | 18891 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.